ニュースDeinove partners with Calibr.Deinove is also working with the non-profit drug discovery group Calibr to explore the anti-infectious potential of the Parisian firm's bacterial collection.
ニュースCalibr partners with AbbVie.The sCAR-T platform technology was developed by Calibr, a division of Scripps Research, and a partnership with AbbVie has enabled this first-in-human trial.
ニュースCalibr is developing T-cell therapies for the treatment of cancers on Jun 1st '18.In June 2018, AbbVie and Calibr, a non-profit drug discovery division of Scripps Research, collaborated to develop T-cell therapies for the treatment of cancers, which also includes solid tumors.
